Older adults who are worried about their thinking, memory, or reasoning skills may want to get tested for Alzheimer’s disease ...

Researchers suggest that the way Alzheimer's reshapes our brains is as unique as our fingerprints, challenging long-held ...

The way in which brains shrink in those who develop Alzheimer's disease follows no specific or uniform pattern, finds a new ...

There is an urgent need to improve access to new innovations in the diagnosis and treatment of Alzheimer's disease. Embracing breakthroughs such as blood-based biomarker testing, has the potential to ...

The CE marking clears the way for the company to market its PET system across the EU after launching in the US market in July ...

Positrigo, a Swiss based company developing nuclear medical imaging devices to advance functional brain imaging, has achieved ...

Doctors can diagnose Alzheimer’s disease with a variety of tests. Those tests include: physical and neurological exams, lab tests, mental status neuropsychological tests, and/or brain imaging like ...

GE HealthCare has secured the FDA’s approval for an injectable, radioactive imaging agent that gives clinicians a clearer ...

Bispecific antibodies (bsAbs) are engineered to target 2 different epitopes simultaneously. About 75% of the 16 clinically ...

The tests will measure blood-based tau markers, offering a possible alternative to PET imaging for aiding in diagnosis and staging of Alzheimer's disease.

The U.S. Food and Drug Administration approved GE HealthCare's diagnostic drug for use in detection of coronary artery ...